Literature DB >> 27641081

The prediction roles of asymmetric dimethyl-arginine, adiponectin and apelin for macroangiopathy in patients with impaired glucose regulation.

Shan Huang1, Dajin Zou2, Wenfang Peng3, Xiaohong Jiang3, Kan Shao3, Lili Xia3, Yubin Tang3.   

Abstract

PURPOSE: To investigate the effects of asymmetric dimethyl-arginine (ADMA), adiponectin (APN) and apelin in predicting macroangiopathy in impaired glucose regulation (IGR) patients.
METHODS: A total of 210 patients undergoing oral glucose tolerance test were included in this study. They were classified to normal glucose tolerance (NGT, n=42), impaired fasting glucose (IFG, n=36), impaired glucose tolerance (IGT, n=92, including 44 IGT1 and 48 IGT2 patients) and IFG+IGT (n=40) groups. APN, apelin and ADMA levels, blood pressure, blood lipid, insulin, body mass index (BMI), and homeostasis model assessment of insulin resistance (HOMA-IR) were detected. The severity and extent of coronary atherosclerosis were determined by the Gensini score.
RESULTS: The prevalence of coronary heart disease and Gensini scores in IGT and IFG+IGT groups were similar but both were higher than NGT and IFG groups (all P<0.05). Lower APN, higher ADMA and apelin levels were witnessed in IGT and IGT+IFG groups compared with NGT and IFG groups (all P<0.05). IGT2 group had higher 2-h PG and apelin levels and Gensini scores but lower APN levels than IGT1 group (all P<0.05). Gensini score was positively correlated with apelin (r=0.669) and ADMA (r=0.764), but were negatively correlated with APN (r=-0.555, all P<0.001). ADMA and APN were the independent factors affecting Gensini score.
CONCLUSION: ADMA and APN levels could be predictive factors for macroangiopathy in IGR patients, especially in IGT cases. Copyright Â
© 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Adiponectin; Adiponectine; Apelin; Asymmetric dimethyl-arginine; Diméthyl-arginine asymétrique; Gensini score; Impaired glucose regulation; Troubles de la glycémie

Mesh:

Substances:

Year:  2016        PMID: 27641081     DOI: 10.1016/j.ando.2016.03.004

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  2 in total

1.  ADMA (asymmetric dimethylarginine) and angiogenic potential in patients with type 2 diabetes and prediabetes.

Authors:  Radosław Wieczór; Anna M Wieczór; Arleta Kulwas; Danuta Rość
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-22

2.  Association of TCM body constitution with insulin resistance and risk of diabetes in impaired glucose regulation patients.

Authors:  Hong You; Tong Zhang; Wen Feng; Yun Gai
Journal:  BMC Complement Altern Med       Date:  2017-09-11       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.